Skip to main content
. 2017 Oct 13;12(10):e0186150. doi: 10.1371/journal.pone.0186150

Table 3. Associations between DNAm, genotypes at meSNPs, and treatment response.

rsID cg Genotype (n) beta at T1 (SD) %Poor responders Genetic association (p value) Chr location MA (%)
(ED)
MA (%)
(UCSC hg19)
Putative function
rs12282251 cg16827215 CC (20) 0.76 (0.06) 75% 0.003 11 11292635 T (0.20) T (0.18) 3’ UTR
CT (13) 0.43 (0.03) 23%
rs34756202 cg01882774 CC (17) 0.83 (0.03) 35% 0.11 14 94491763 T (0.30) T (0.26) Intron/upstream
CT (12) 0.50 (0.10) 83%
TT (4) 0.07 (0.03) 50%
rs7933565 cg19680693 GG (12) 0.83 (0.04) 42% 0.10 11 94111808 A (0.45) A (0.53) 3’ UTR
GA (12) 0.52 (0.07) 50%
AA (9) 0.11 (0.05) 78%
rs66630638 cg08891829 GG (22) 0.93 (0.01) 36% 0.002 4 56231728 A (0.16) A (0.14) intron
AG (10) 0.52 (0.05) 90%
AA (1) 0.04 (-) 100%
rs73006518 cg22843488 CC (22) 0.90 (0.02) 41% 0.015 3 151017685 T (0.19) T (0.06) intron
CT (9) 0.67 (0.10) 78%
TT (2) 0.13 (0.02) 100%
rs76828276 cg05187322 CC (24) 0.90 (0.02) 42% 0.010 17 78152328 T (0.12) T (0.07) 5’ UTR
CT (9) 0.49 (0.04) 89%

Note: Minor allele and frequencies from current ED study and UCSC (hg19) were listed. For the genetic association tests, additive models were used. No effects of age, sex or race on the responder status were detected.